Macrogenics Inc (NASDAQ: MGNX) open the trading on Wednesday, with a bit cautious approach as it glided -6.35% to $1.18, before settling in for the price of $1.26 at the close. Taking a more long-term approach, MGNX posted a 52-week range of $0.99-$17.24.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 45.47%. Meanwhile, its Annual Earning per share during the time was 19.47%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -140.19%. This publicly-traded company’s shares outstanding now amounts to $62.82 million, simultaneously with a float of $58.00 million. The organization now has a market capitalization sitting at $74.44 million. At the time of writing, stock’s 50-day Moving Average stood at $2.0370, while the 200-day Moving Average is $3.2547.
Macrogenics Inc (MGNX) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Macrogenics Inc’s current insider ownership accounts for 8.07%, in contrast to 84.03% institutional ownership. According to the most recent insider trade that took place on Feb 15 ’25, this organization’s VP, Controller & Treasurer sold 423 shares at the rate of 2.56, making the entire transaction reach 1,083 in total value, affecting insider ownership by 9,532.
Macrogenics Inc (MGNX) Earnings and Revenue Records
Macrogenics Inc’s EPS decrease for this current 12-month fiscal period is -140.19% and is forecasted to reach -1.75 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -28.62% through the next 5 years, which can be compared against the 19.47% growth it accomplished over the previous five years trading on the market.
Macrogenics Inc (NASDAQ: MGNX) Trading Performance Indicators
Let’s observe the current performance indicators for Macrogenics Inc (MGNX). It’s Quick Ratio in the last reported quarter now stands at 3.92. The Stock has managed to achieve an average true range (ATR) of 0.15. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.50.
In the same vein, MGNX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.07, a figure that is expected to reach -0.73 in the next quarter, and analysts are predicting that it will be -1.75 at the market close of one year from today.
Technical Analysis of Macrogenics Inc (MGNX)
[Macrogenics Inc, MGNX] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 71.26% While, its Average True Range was 0.1480.
Raw Stochastic average of Macrogenics Inc (MGNX) in the period of the previous 100 days is set at 6.83%, which indicates a major fall in contrast to 36.54% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 105.07% that was higher than 71.36% volatility it exhibited in the past 100-days period.
